Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Allow lyophilized vials to reach room temperature before reconstitution to reduce condensation moisture
TRIUMPH-1 (NCT05929066), the Phase 3 registration trial for the obesity indication, reported topline results on May 21, 2026 : average weight loss of 28.3% at 80 weeks at the highest dose in 2,339 participants, versus 2.2% on placebo, and 30.3% at 104 weeks among participants with a BMI of 35 or above who continued in a pre-specified extension
Ideal for me and my husband
Rise assessment Your personalized assessment will appear here after calculation
Heres what people may want to know
It is CagriSema: cagrilintide 2.4 mg combined with semaglutide 2.4 mg
US$ 24.86
US$ 21.55
US$ 23.36
US$ 27.58
US$ 25.95
US$ 26.81
US$ 25.38
US$ 26.52
US$ 28.56
US$ 28.67
US$ 26.86
